A Double-Blind Placebo-Controlled Study of Lamotrigine Monotherapy in Outpatients With Bipolar I Depression
The DOI matches its Crossref record.
Abstract
BACKGROUND: More treatment options for bipolar depression are needed. Currently available antidepressants may increase the risk of mania and rapid cycling, and mood stabilizers appear to be less effective in treating depression than mania. Preliminary data suggest that lamotrigine, an established antiepileptic drug, may be effective for both the depression and mania associated with bipolar disorder. This is the first controlled multicenter study evaluating lamotrigine monotherapy in the treatment of bipolar I depression. METHODS: Outpatients with bipolar I disorder experiencing a major depressive episode (DSM-IV, N = 195) received lamotrigine (50 or 200 mg/day) or placebo as monotherapy for 7 weeks. Psychiatric evaluations, including the Hamilton Rating Scale for Depression (HAM-D), the Montgomery-Asberg Depression Rating Scale (MADRS), Mania Rating Scale, and the Clinical Global Impressions scale for Severity (CGI-S) and Improvement (CGI-I) were completed at each weekly visit. RESULTS: Lamotrigine 200 mg/day demonstrated significant antidepressant efficacy on the 17-item HAM-D, HAM-D Item 1, MADRS, CGI-S, and CGI-I compared with placebo. Improvements were seen as early as week 3. Lamotrigine 50 mg/day also demonstrated efficacy compared with placebo on several measures. The proportions of patients exhibiting a response on CGI-I were 51%, 41%, and 26% for lamotrigine 200 mg/day, lamotrigine 50 mg/day, and placebo groups, respectively. Adverse events and other safety results were similar across treatment groups, except for a higher rate of headache in the lamotrigine groups. CONCLUSION: Lamotrigine monotherapy is an effective and well-tolerated treatment for bipolar depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while clinical experience and the results of many studies suggest that response to mood stabilizers and antipsychotics is similar in BDII and BDI, there are enough exceptions to suggest this should not be taken for granted.248, 405, 431”
Citations
Cites
Still being checked.
Cited by
Items 701–800 of 1,000
Where Does Lamotrigine Fit in the Pharmacotherapy of Mood Disorders? An Evidence-Based Appraisal
Goldberg, J. F. (2024) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.23ac15219 · Cited by 2
Gao, K., & Calabrese, J. R. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as41 · Cited by 2
Self-citationBipolar depression in primary care: a hidden threat.
Lewis, F. T. (2004) · PubMed · Cited by 2
Williams, D. T., Hirsch, S., & Coffey, B. J. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2007.17503 · Cited by 2
Anticonvulsant monitoring in psychiatric practice
Nelson, D., & Gray, D. (2001) · Psychiatric Bulletin · doi:10.1192/pb.25.9.356 · Cited by 2
How can we classify “mood stabilizers” with different properties?
Kondo, T. (2011) · Clinical Neuropsychopharmacology and Therapeutics · doi:10.5234/cnpt.2.12 · Cited by 2
Pharmacological Profile and Clinical Utility of Lamotrigine in Mood Disorders
van der Loos, M. L. M., Calabrese, J. R., Nolen, W. A., & Muzina, D. J. (2011) · Wiley eBooks · doi:10.1002/9780470975114.ch4 · Cited by 2
Self-citationPost, R. M. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544187.024 · Cited by 2
Evaluating the Tolerability of the Newer Mood Stabilizers
Alao, A. O., & Dewan, M. J. (2001) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200101000-00012 · Cited by 2
Efficacy of Olanzapine for Treating Depressive Episodes in Bipolar Disorder
Kirino, E. (2014) · Clinical Neuropsychopharmacology and Therapeutics · doi:10.5234/cnpt.5.11 · Cited by 2
Declarative Memory in Patients With Bipolar Disorder and Stimulant Abuse Receiving Lamotrigine
Osuji, I. J., Tucker, E., & Brown, E. S. (2008) · Journal of Dual Diagnosis · doi:10.1080/15504260802073535 · Cited by 2
Update and long-term clinical management of rapid cycling
Montes, J. M. G., & Lahera, G. (2007) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000224796.36653.c3 · Cited by 2
Lamotrigine for bipolar disorder: translating research into clinical practice
Fung, J., Mok, H., & Yatham, L. N. (2004) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.4.3.363 · Cited by 2
Pharmacologic Treatment of Bipolar Disorder
Baldassano, C. F. (2010) · CNS Spectrums · doi:10.1017/s1092852900027772 · Cited by 2
Cleaning Up Evidence-Based Psychopharmacology
Osser, D. N. (2008) · Psychopharm Review · doi:10.1097/01.idt.0000311517.65367.cf · Cited by 2
Bowden, C. L., Gitlin, M. J., Keck, P. E., Perlis, R. H., Thase, M. E., & Wagner, K. D. (2002) · Cited by 3
Self-citationCoplan, J. D., Gupta, N. K., Flynn, S. K., Reiner, W. J., Gaita, D. J., Fulton, S. L., Rozenboym, A. V., Tang, J. E., Cooper, T. B., & Mann, J. J. (2018) · Chronic Stress · doi:10.1177/2470547018785625 · Cited by 2
Pharmacological Treatment Strategies for Acute Bipolar Depression
Kim, S. J. (2018) · 신경정신의학 · doi:10.4306/jknpa.2018.57.4.287 · Cited by 2
Vandevelde, A., Benbrika, S., Madigand, J., & Dollfus, S. (2021) · L Encéphale · doi:10.1016/j.encep.2020.10.004 · Cited by 2
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.024 · Cited by 2
Geddes, J. R., & Briess, D. (2007) · PubMed Central · Cited by 6
Treatment of bipolar depression: focus on pharmacologic therapies
Mitchell, P. B., & Malhi, G. S. (2005) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.5.1.69 · Cited by 2
The basis for the use of antiepileptic drugs in psychiatric disorders
Malt, U. F. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.00202-22.x · Cited by 2
Improving identification of treatment effectiveness in bipolar disorders
Bowden, C. L. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00029.x · Cited by 2
Self-citationEmerging roles of new antipsychotics in bipolar disorders
Wang, P. W., & Ketter, T. A. (2003) · Current Psychosis & Therapeutics Reports · doi:10.1007/bf02629382 · Cited by 2
Update on the use of new anticonvulsants as mood stabilisers
Maidment, I. (1999) · Psychiatric Bulletin · doi:10.1192/pb.23.9.554 · Cited by 2
Bipolar Disorders: A Brief Guide to Diagnosis and Treatment
Jefferson, J. W. (2003) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.1.1.7 · Cited by 2
Topiramate in the Management of Bipolar Disorder
Chengappa, K. N. R., Axelson, D., & Birmaher, B. B. (2001) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.6.6.1.22462 · Cited by 2
Lamotrigine — An Effective Mood Stabilizer?
Maidment, I. (1999) · Annals of Pharmacotherapy · doi:10.1345/aph.18388 · Cited by 2
Holtzheimer, P. E., & Neumaier, J. F. (2003) · CNS Spectrums · doi:10.1017/s1092852900028698 · Cited by 2
Bowden, C. L., Calabrese, J. R., Cookson, J., & Monaghan, E. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00199-7 · Cited by 2
Self-citationAnticonvulsants Used in Child and Adolescent Psychiatric Disorders
Pavuluri, M. N., & Mayanil, T. (2012) · Wiley eBooks · doi:10.1002/9781119958338.ch12 · Cited by 1
Application of Anesthetic Agents in Depression
Vutskits, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93273-8.00026-2 · Cited by 1
Shafiq, S., Ronksley, P. E., Elliott, M. J., Bulloch, A. G. M., & Patten, S. B. (2025) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251355643 · Cited by 2
PHARMAC and treatment of bipolar depression--the limits of utilitarianism.
Ellis, P., Mulder, R., & Porter, R. (2006) · PubMed · Cited by 1
Muneoka, K. T., Kon, K., Kawabe, M., Ui, R., Miura, T., Iimura, T., & Kimura, S. (2012) · Case Reports in Medicine · doi:10.1155/2012/736521 · Cited by 1
Anticonvulsant Strategies for Treating Bipolar Disorder: What Works, What Doesn't
Goodnick, P. J. (2014) · Cited by 1
Medikamente zur Behandlung bipolarer affektiver Störungen
Grunze, H., & Bauer, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_54 · Cited by 4
Mental Health and Behavioral Disorders in Pregnancy
Wisner, K. L., Sit, D. K. Y., Altemus, M. M., Bogen, D. L., Famy, C. S., Pearlstein, T. B., Misra, D. P., Reynolds, S. K., & Perel, J. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1935-2.00052-1 · Cited by 3
Chávez-León, E. (2004) · Salud Mental · Cited by 1
Pharmacological treatment of acute bipolar depression
Sachs, G. S., Sylvia, L. G., & Lund, H. G. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_9 · Cited by 1
Self-citationTherapeutics of pediatric bipolar disorder
Kowatch, R. A., DelBello, M. P., & Gracious, B. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.012 · Cited by 1
A case series of lamotrigine increased to 300 mg daily in patients with bipolar depression
Abraham, P. F. (2011) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2011.05.007 · Cited by 1
Pharmacoepidemiology of Bipolar Disorder: A Review
Dimellis, D., & Konstantinos, N. (2015) · Cited by 2
Essential Pharmacotherapies for Bipolar Disorder
Ruegg, H., Adler, C. M., Durán, L. R. P., Watson, S., & DelBello, M. P. (2019) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-018-0162-0 · Cited by 1
Pharmacological Treatment of Bipolar Depression
Young, A. H., & Nemeroff, C. B. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch23 · Cited by 1
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.083 · Cited by 1
Bocchetta, A. (2010) · Wiley eBooks · doi:10.1002/9780470749180.ch7 · Cited by 1
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.045 · Cited by 2
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.018 · Cited by 1
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.032 · Cited by 1
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.086 · Cited by 1
Kwak, K. (2007) · Journal of Korean Medical Association · doi:10.5124/jkma.2007.50.4.348 · Cited by 1
A linear relationship between lamotrigine and GABA in cerebrospinal fluid
Bebitoğlu, B. T. (2011) · MARMARA PHARMACEUTCAL JOURNAL · doi:10.12991/201115437 · Cited by 1
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.046 · Cited by 1
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.055 · Cited by 1
Stahl, S. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108921275.071 · Cited by 1
Psychopharmacological Recovery-Oriented Treatments in Bipolar Disorders
Cuomo, A., Spiti, A., Chioccioli, M., Koukouna, D., Goracci, A., Bolognesi, S., & Fagiolini, A. M. (2022) · Comprehensive approach to psychiatry · doi:10.1007/978-3-030-98301-7_12 · Cited by 1
Medvedev, V. E., & KUZNETSOVA, I. (2023) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2023-6-18-26 · Cited by 1
Bipolar affective disorder occurring with psychopharmacotherapy-induced manic phases
Shteinberg, A. S., An, B., Березкин, А. С., & Sorokin, S. A. (2024) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20241240619 · Cited by 1
On the Process of Finding Novel and Selective Sodium Channel Blockers for the Treatment of Diseases
Priest, B. T. (2008) · Topics in medicinal chemistry · doi:10.1007/7355_2008_019 · Cited by 1
Evidenzbasierte Medizin in der klinischen Praxis
Vasić, N., Wolf, R. C., & Connemann, B. J. (2008) · Nervenheilkunde · doi:10.1055/s-0038-1627213 · Cited by 1
Reply to Modafinil: Mischaracterization
Biederman, J. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0624c · Cited by 1
Atypical antipsychotics in the therapy of bipolar disorders: efficacy and safety
Lorenzo, R. D., & Genedani, S. (2002) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2.3.363 · Cited by 1
Rash and lamotrigine in bipolar patients
Pae, C. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.09.018 · Cited by 1
Anti–Epileptic Drugs (AEDs) in the Treatment of Aggression in Children and Adolescents
Trivedi, H. K., Wang, B. H., & Gonzalez–Heydrich, J. (2005) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.10.1.6.67067 · Cited by 2
Bipolar depression: What are we doing?
Bonetto, G. G., Garbini, M., & Vieta, E. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.08.002 · Cited by 1
Kusumakar, V., Greene, P., Earl, N., Ascher, J. A., Monaghan, E., Smoot, T., Fouche, N., Bowden, C. L., Calabrese, J. R., Post, R. M., et al. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)80179-0 · Cited by 1
Self-citationVieta, E. (2013) · doi:10.1007/978-1-908517-94-4_4 · Cited by 1
Clare, J. J. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7411-x_2 · Cited by 1
Antidepressant treatment of bipolar depression
Möller, H., & Grunze, H. (2000) · Springer eBooks · doi:10.1007/0-306-47521-9_19 · Cited by 1
Keßler, U. (2014) · NVA (Nasjonalt vitenarkiv) · Cited by 2
ESCALA CLÍNICA PARA PREVER A ADESÃO AO TRATAMENTO: TRANSTORNO BIPOLAR DO HUMOR
Marchi, R. J. D. (2008) · Americanae (AECID Library) · Cited by 2
Case Studies in Bipolar Depression: Best Practices for the Outpatient
Keck, P. E., McIntyre, R. S., & Shelton, R. C. (2007) · CNS Spectrums · doi:10.1017/s1092852900015893 · Cited by 1
Benazzi, F. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544187.019 · Cited by 1
Toniolo, R. A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-07122016-150647 · Cited by 2
When medication fails: Neurostimulation therapies for depression.
Carpenter, L. L., Megna, J. L., Herrera-Rojas, M., & Siddiqui, U. A. (2011) · Cited by 1
Emerging Therapies for Bipolar Depression
Marangell, L. B., Kupfer, D. J., Sachs, G. S., & Swann, A. C. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0718 · Cited by 1
Self-citationPharmakotherapie bipolarer Störungen
Koch, T. (2001) · pharma-kritik · doi:10.37667/pk.2000.342 · Cited by 1
Gene expression and genetic association in bipolar disorder
Sears, C. (2012) · Otago University Research Archive (University of Otago) · Cited by 1
Clinical Psychopharmacology and Other Somatic Therapies
Perry, P. J., Wehring, H. J., ALEXANDER, B. K., & Liskow, B. I. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-252-6_34 · Cited by 1
Razionale farmacologico per l’utilizzazione della quetiapina nel disturbo bipolare
Spina, E. (2006) · Giornale italiano di psicopatologia/Journal of psychopathology/Italian journal of psychopathology
Kiselycznyk, C., & Sanacora, G. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1056-4_17
Englund, M. (2007) · Figshare
Thase, M. E. (2008) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544187.029
Nuevos antiepilépticos, ¿nuevas alternativas terapéuticas?
Barrios, J. C. N., Andueza, R. M., & Prados, A. C. (2002) · Redalyc (Universidad Autónoma del Estado de México)
Segarra, R., Gutiérrez, M., Eguiluz, I., & Rodriguez, M. (2002) · Psiquiatría Biológica
McGrath, P. J., & Roose, S. P. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139175869.004
Reproduktive Auffälligkeiten bei unmedizierten Frauen mit bipolarer Erkrankung
Schoofs, N. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-17913
Medikamente zur Behandlung bipolarer affektiver Störungen
Grunze, H., & Forsthoff, A. (2008) · Springer eBooks · doi:10.1007/978-3-540-68748-1_29
Neurobiology and Treatment of Depression
Neumeister, A., Charney, D. S., Sanacora, G., & Krystal, J. H. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn018 · Cited by 1
A Different Mechanism to Understand Activation/Sedation Side Effects of Ziprasidone
Brophy, M. H. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0624f
The acute treatment of bipolar depression: Historically relevant and recent controlled trials
Kronstein, P. D., & Zarate, C. A. (2006) · Current Psychosis & Therapeutics Reports · doi:10.1007/bf02629389
Pae, C.-U., Han, C., Marks, D. M., & Patkar, A. A. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.10.012
A one-year continuation study of lamotrigine treatment in bipolar depression
Huffman, R., Ascher, J. A., Earl, N., Monaghan, E., Womble, G. P., Mitchell, P. B., Cookson, J., Vanier, B., Dinan, T. G., & Calabrese, J. R. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)80177-7
Self-citationPharmacological Treatments for Bipolar Disorder: An Update
Kusumakar, V., & Kutcher, S. (2001) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.6.1.7.19168
Weight Gain with Antipsychotic Medications in Children and Adolescents
Kotler, L. A., & Devlin, M. J. (2001) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.6.6.5.22460
Recent Progress in the Pharmacotherapy of Bipolar Disorder
Mitchell, P. B., Loo, C. K. A., & Breakspear, M. J. (2009) · Future Neurology · doi:10.2217/fnl.09.18
Metadata
- Authors
- Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group
- Affiliations
- Case Western Reserve University (US)
- GlaxoSmithKline (United Kingdom) (GB)
- ORCID
- Calabrese, Joseph R.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1999-02-15
- Volume
- 60
- Issue
- 2
- Pages
- 79-88
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2058120764
- Cited by
- 1,054
- References
- 0
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 15 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 162 · 2019: 10 · 2018: 13 · 2017: 13 · 2016: 13 · 2015: 18 · 2014: 23 · 2013: 24 · 2012: 34
- FWCI
- 47.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- lamotrigine, bipolar I depression, bipolar disorder, antidepressant monotherapy, antiepileptic drugs, major depressive episode, treatment response, adverse events, headache, drug tolerability
- MeSH terms
- Lamotrigine, Adult, Aged, Ambulatory Care, Anticonvulsants, Bipolar Disorder, Depressive Disorder, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Patient Compliance, Placebos, Psychiatric Status Rating Scales, Severity of Illness Index, Triazines, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.